
|Articles|May 18, 2020
ActiGraph Announces Acquisition by ArchiMed
Advertisement
ActiGraph has announced that it has been acquired ArchiMed. Their investment in ActiGraph’s employees, technology, and capabilities will allow the company to expand its patient monitoring solutions portfolio to support the development of therapies. The company’s digital remote monitoring platform is particularly well-suited for site less/virtual trials, which have become fundamental to sustaining clinical research and protecting patients amid the COVID-19 pandemic.
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5




